ARCHIVES

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

This article is from The Cancer Letter archive.

Vol. 12 No. 37 | September 26, 1986

Download PDF Visit The Full Archive

Related Articles

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

DRCCA Board Gives Concept Approval To Nutrition Clinical Trials Which Could Total $52.5 Million

January 28, 1983

Mark Israel To Direct Norris Cotton Center

October 19, 2001

CTEP Director Friedman Adds To Article On Minority Initiative

March 23, 1990

NIH Director’s Office Funds $106 Million In Cancer Grants With Stimulus Dollars

September 18, 2009

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003